Skip to main content
Log in

Plötzlicher Herztod bei Sportlern und dessen Prävention

Sudden cardiac death in athletes and its prevention

  • Schwerpunkt
  • Published:
Herz Aims and scope Submit manuscript

Zusammenfassung

Sportler und insbesondere Leistungssportler sind meist junge Menschen, mit denen kein erhöhtes Gesundheitsrisiko, es sei denn für Traumata, assoziiert wird. Es kommt aber signifikant häufiger zu Fällen des plötzlichen Herztodes (PHT) in dieser Gruppe. Die Inzidenz des PTH bei Sportlern bewegt sich zwischen 0,6 und 3,0/100.000 pro Jahr. Häufig ist der PHT hier das erste Erscheinungsbild einer zugrunde liegenden kardialen Grunderkrankung. Dazu gehören strukturelle Erkrankungen wie hypertrophe Kardiomyopathie, Koronaranomalien, Myokarditis, koronare Herzerkrankung und arrhythmogene rechtsventrikuläre Kardiomyopathie, aber auch Erkrankungen ohne strukturelle Herzveränderungen wie Ionenkanalerkrankungen. Durch ein einfaches Screening können viele dieser Erkrankungen erkannt und Behandlungen oder Vorsichtsmaßnahmen eingeleitet werden.

Abstract

Athletes and especially elite athletes are predominantly young people and are not associated with high health risks, apart from traumatic injuries. Nevertheless, there is a significantly high incidence of sudden cardiac death (SCD), which ranges from 0.6 to 3.0/100,000 athletes per year. Often the SCD is the first manifestation of an underlying cardiac disease. Distinct structural cardiac disorders, such as hypertrophic cardiomyopathy, coronary artery anomalies (17 %), inflammatory disorders (6 %) and arrhythmogenic right ventricular cardiomyopathy as well as conditions without structural cardiac abnormalities, such as primary electrical diseases (channelopathies) are important causes of sudden death. A simple screening can help to identify athletes with these diseases and allow specific therapies or precautionary measures to be initiated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Thompson PD, Franklin BA, Balady GJ et al; American Heart Association Council on Nutrition, Physical Activity, and Metabolism, American Heart Association Council on Clinical Cardiology, American College of Sports Medicine (2007) Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation 115:2358–2368

    Article  PubMed  Google Scholar 

  2. Corrado D, Basso C, Pavei A et al (2006) Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening programme. JAMA 296:1593–1601

    Article  CAS  PubMed  Google Scholar 

  3. Albert CM, Mittleman MA, Chae CU et al (2000) Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 343:1355–1361

    Article  CAS  PubMed  Google Scholar 

  4. Thompson PD, Funk EJ, Carleton RA et al (1982) Incidence of death during jogging in Rhode Island from 1975 through 1980. JAMA 247:2535–2538

    Article  CAS  PubMed  Google Scholar 

  5. Maron BJ, Doerer JJ, Haas TS et al (2009) Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation 119:1085–1092

    Article  PubMed  Google Scholar 

  6. Corrado D, Basso C, Rizzoli G et al (2003) Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 42:1959–1963

    Article  PubMed  Google Scholar 

  7. Marijon E, Tafflet M, Celermajer DS et al (2011) Sports-related sudden death in the general population. Circulation 124:672–681

    Article  PubMed  Google Scholar 

  8. Kim JH, Malhotra R, Chiampas G et al; Race Associated Cardiac Arrest Event Registry (RACER) Study Group (2012) Cardiac arrest during long-distance running races. N Engl J Med 366:130–140

    Article  CAS  PubMed  Google Scholar 

  9. Corrado D, Schmied C, Basso C et al (2011) Risk of sports: do we need a pre-participation screening for competitive and leisure athletes? Eur Heart J 32:934–944

    Article  PubMed  Google Scholar 

  10. Elliot PM, Poloniecki J, Dickie S et al (2000) Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36:2212–2218

    Article  Google Scholar 

  11. Cheitlin MD, MacGregor J (2009) Congenital anomalies of coronary arteries. Herz 34:268–279

    Article  PubMed  Google Scholar 

  12. Maron BJ (2003) Sudden death in young athletes. N Engl J Med 349:1064–1075

    Article  CAS  PubMed  Google Scholar 

  13. Basso C, Corrado D, Bauce B, Thiene G (2012) Arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol 5:1233–1246

    Article  PubMed  Google Scholar 

  14. Maisch B, Pankuweit S (2013) Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives. Heart Fail Rev 18:761–795

    Article  CAS  PubMed  Google Scholar 

  15. Maisch B, Ruppert V, Pankuweit S (2014) Management of fulminant myocarditis: a diagnosis in search of its etiology but with therapeutic options. Curr Heart Fail Rep 11:166–177

    Article  CAS  PubMed  Google Scholar 

  16. Chimenti C, Pieroni M, Frustaci A et al (2006) Myocarditis: when to suspect and how to diagnose it in athletes. J Cardiovasc Med 7:301–306

    Article  Google Scholar 

  17. Heidbuchel H, Corrado D, Biffi A et al (2006) Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part II: ventricular arrhythmias, channelopathies and implantable defibrillators. Eur J Cardiovasc Prev Rehabil 13:676–686

    Article  PubMed  Google Scholar 

  18. Viskin S, Wilde AAM, Guevara-Valdivia ME (2013) Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries. J Am Coll Cardiol 61:2383–2387

    Article  PubMed  Google Scholar 

  19. Di Paolo FM, Schmied C, Zerguini YA et al (2012) The athlete’s heart in adolescent Africans: an electrocardiographic and echocardiographic study. J Am Coll Cardiol 59:1029–1036

    Article  Google Scholar 

  20. Corrado D, Pelliccia A, Heidbuchel H et al (2010) Recommendations for interpretation of 12-lead electrocardiogram in the athlete. EHJ 31:243–259

    Article  Google Scholar 

  21. Schimpf R, Veltmann C, Wolpert C et al (2009) Channelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT. Herz 34:281–288

    Article  PubMed  Google Scholar 

  22. Maron BJ, Thompson PD, Puffer JC et al (2007) Cardiovascular preparticipation screening of competitive athletes. A statement from the Sudden Death Committee (Clinical Cardiology) and Congenital Cardiac Defects Committee (Cardiovascular Disease in the Young), American Heart Association. Circulation 115:1–13

    Article  Google Scholar 

  23. Corrado D, Pelliccia A, Bjornstad HH et al (2005) Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus statement of the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial diseases of the European Society of Cardiology. Eur Heart J 26:516–524

    Article  PubMed  Google Scholar 

  24. Ljungqvist A, Jenoure P, Engebretsen L et al (2009) The International Olympic Committee (IOC) consensus statement on periodic health evaluation of elite athletes March 2009. Br J Sports Med 43:631–643

    Article  PubMed  Google Scholar 

  25. Maron BJ, Zipes DP (2005) 36th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol 45:1373–1375

    Article  PubMed  Google Scholar 

  26. Baggish AL, Hutter AM Jr, Wang F et al (2010) Cardiovascular screening in college athletes with and without electrocardiography: a cross-sectional study. Ann Intern Med 152:269–275

    Article  PubMed  Google Scholar 

  27. Ryan MP, Cleland JG, French JA et al (1995) The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy. Am J Cardiol 76:689–694

    Article  CAS  PubMed  Google Scholar 

  28. Corrado D, Basso C, Schiavon M et al (1998) Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 339:364–369

    Article  CAS  PubMed  Google Scholar 

  29. Maron BJ, Gardin JM, Flack JM et al (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation 92:785–789

    Article  CAS  PubMed  Google Scholar 

  30. Pelliccia A, Di Paolo FM, Corrado D et al (2006) Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J 27:2196–2200

    Article  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. T. Tönnis, C. Tack und K.-H. Kuck geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Tönnis.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tönnis, T., Tack, C. & Kuck, KH. Plötzlicher Herztod bei Sportlern und dessen Prävention. Herz 40, 379–385 (2015). https://doi.org/10.1007/s00059-015-4225-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-015-4225-3

Schlüsselwörter

Keywords

Navigation